Chelsea football club are playing against Zenit St Peterborough tonight in the UEFA Champions league last match of the group stages away from the Stamford Bridge.
This match is not that crucial to Chelsea because they have already progressed to the next stage of the Champions league.
However, the Chelsea fans were furious with the selection of Saul Niguez as they believe he is a week player who will cost the team.
Take a look at some of the reactions from the Chelsea fans:
Matthew: " I don't get why the Saul experiment keeps happening. He can't hack it in the PL. Not sure what the end game is playing him when it's known his loan is being ended early on Jan 1."
Nicholas: " As expected. Tuchel doing funny things again accommodating weak players likes Saul by playing two midfielders with him. Timo Cho Mason Ross gonna take some share of Lukaku's running
Don't expect much since we've qualified. So no pressure just get some chemistry going."
Content created and supplied by: TaylorNews (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More